T

Theriva Biologics
D

TOVX

1.55000
USD
-0.05
(-3.13%)
مغلق
حجم التداول
225
الربح لكل سهم
-10
العائد الربحي
-
P/E
-0
حجم السوق
4,312,796
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
الأخبار
المقالات

العنوان: Theriva Biologics Inc

القطاع: Healthcare
الصناعة: Biotechnology
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break downthe tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.